Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
AUPH | Aurinia Pharmaceuticals Inc. | EVP, Research and Development | $1.95M | -$168K | -7.94% | Feb 27, 2024 |
GWPH | GW PHARMACEUTICALS PLC | Chief Medical Officer | May 5, 2021 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|